Urinary and Sexual Function Before and After Surgical Decompression of Cervical Myelopathy
1 other identifier
observational
76
1 country
1
Brief Summary
Hypotheses: Decompressive surgery of cervical myelopathy will improve bladder function. Decompressive surgery of cervical myelopathy will improve sexual function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 7, 2014
CompletedFirst Posted
Study publicly available on registry
February 11, 2014
CompletedStudy Start
First participant enrolled
March 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2016
CompletedFebruary 11, 2014
February 1, 2014
1.9 years
February 7, 2014
February 10, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
JOA (Japanese Orthopaedic Association) Scores for cervical myelopathy
This score will provide patients' conditions at a glance.
6 months after surgery
Secondary Outcomes (1)
Bladder compliance
6 months after surgery
Other Outcomes (2)
Rigidity activity unit of penis
6 months after surgery
Female sexual function index
6 months after surgery
Study Arms (1)
Decompression of cervical myelopathy
JOA (Japanese Orthopaedic Association) Scores for cervical myelopathy Compliance Rigidity activity unit
Eligibility Criteria
Patients having cervical myelopathy, aged between 25 and 65
You may qualify if:
- evidence of progression of motor or sensory nerve
- cervical myelopathy in magnetic resonance imaging
You may not qualify if:
- radical pelvic surgery
- pelvic irradiation
- evidence of brain damage (dementia, cerebrovascular disease)
- evidence of psychotic disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Vincent's Hospital, The Catholic University of Korea
Suwon, Gyeonggi-do, 442-723, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ilsup Kim, MD, PhD
The Catholic University of Korea
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior researcher
Study Record Dates
First Submitted
February 7, 2014
First Posted
February 11, 2014
Study Start
March 1, 2014
Primary Completion
February 1, 2016
Study Completion
August 1, 2016
Last Updated
February 11, 2014
Record last verified: 2014-02